Insurance Services Co.India, is a fast growing Financial Planning and investment advisory firm, based at Raipur, which is one of the rapid economic growth hubs of India.

Insurance Services India has started in April 2001 and is currently managing asset portfolios of over 91 domestic clients and 8 NRI clients. The company’s clients form a wide spectrum of professionals that includes Banking, IT, Telecom, Manufacturing, Business, Medicine, Architecture, and more. The desire to help our clients meet their financial goals is at the epicenter of the company’s policies. Personal attention and quarterly portfolio review given to each client to ensure high customer satisfaction are some of our key differentiator.

It is our belief that by providing a personalized and consistent service experience, we ensure long and fruitful relationships with our clients.

The goal is to create, grow and preserve wealth. The advisory practice is built on the foundation of trust, integrity and responsibility and hence we are always committed to exceeding the expectations of the clients. Across all solutions, our first exercise is to discuss with you extensively to understand your context, aspirations and constraints. We prefer working with our clients over multiple years rather than focusing on one-off transactions. Irrespective of which services you choose, we will be committed to provide you quality service over the long term. Client Loyalty is extremely important to us as most of the client relationships we have are only by invitation and we do not indulge in any mass marketing strategies.


Regular investing in MF schemes reached a new milestone, with SIP accounts crossing 4 crore and SIP AUM reaching an all-time high of Rs 483,964 crore
Fri, 09 Jul 2021 12:12:17 +0530


The company will separately announce price band and lot size for its IPO in coming few days. The issue will close on August 6.
Wed, 28 Jul 2021 18:55:01 +0530


The price band for the offer could be disclosed separately by the company in coming days. The issue will close on August 6.
Wed, 28 Jul 2021 13:12:35 +0530


Arihant Capital has come out with its report on Rolex Rings. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 27, 2021.
Wed, 28 Jul 2021 12:29:56 +0530


KR Choksey has come out with its report on Rolex Rings. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 28, 2021.
Wed, 28 Jul 2021 12:23:59 +0530


Considering the business growth outlook and almost stable operating margins, Choice Broking assigned a #39;subscribe#39; rating to the issue.
Wed, 28 Jul 2021 11:42:58 +0530


Rolex Rings IPO: At the upper band of IPO price of Rs 900, it is valued at a P/E multiple of 35 (on recalculated EPS excluding the Rs 25 crore deferred tax credit) which is lower than the industry average of 83, said KR Choksey Research.
Wed, 28 Jul 2021 11:27:06 +0530


Rolex Rings IPO: At higher price band of Rs 900, Rolex Rings is demanding a price-to-earnings (P/E) valuation of 28.2x (to its restated FY21 EPS of Rs 31.9) with a market cap of Rs 2,451 crore, while its peers namely Ramkrishna Forgings and MM Forgings are trading at a P/E of 123.30 and 37.14, respectively
Wed, 28 Jul 2021 08:57:45 +0530


Marquee investors participated in the anchor book were Invesco Mutual Fund, Matthews Asia Funds, and HSBC Global Investment Funds.
Tue, 27 Jul 2021 20:21:21 +0530


The public issue will be open for subscription between July 28-30.
Tue, 27 Jul 2021 15:45:53 +0530


Geojit has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 24, 2021.
Tue, 27 Jul 2021 13:43:51 +0530


Ajcon Global has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 26, 2021.
Tue, 27 Jul 2021 13:38:08 +0530


Arihant Capital has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 26, 2021.
Tue, 27 Jul 2021 13:30:59 +0530


Choice Equity Broking has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 23, 2021.
Tue, 27 Jul 2021 13:24:19 +0530


The subsidiary of Glenmark Pharma plans to raise Rs 1,513.6 crore through the public issue which comprises a fresh issue of Rs 1,060 crore, and an offer for sale of 63 lakh equity shares by promoter.
Tue, 27 Jul 2021 11:27:19 +0530


Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible.
Tue, 27 Jul 2021 09:26:50 +0530

Video Box